Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.

Saved in:
Bibliographic Details
Title: Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
Authors: Kalkowska DA; Kid Risk, Inc., Orlando, FL, USA., Pallansch MA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wilkinson A; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bandyopadhyay AS; Bill and Melinda Gates Foundation, Seattle, WA, USA., Konopka-Anstadt JL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Badizadegan K; Kid Risk, Inc., Orlando, FL, USA., Thompson KM; Kid Risk, Inc., Orlando, FL, USA.
Source: Risk analysis : an official publication of the Society for Risk Analysis [Risk Anal] 2021 Feb; Vol. 41 (2), pp. 329-348. Date of Electronic Publication: 2020 Nov 10.
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Blackwell Publishers Country of Publication: United States NLM ID: 8109978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-6924 (Electronic) Linking ISSN: 02724332 NLM ISO Abbreviation: Risk Anal Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first